SRSF2 and acute myeloid leukemia: The E7107 molecule seemed promising since in mouse models of AML bearing a mutated SRSF2 gene (inducible knock-in or patient cell xenografts), this spliceosome inhibitor killed more efficiently SRSF2-mutated cells.